HSBC Holdings’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Sell |
6,292
-9,999
| -61% | -$431K | ﹤0.01% | 2053 |
|
|
2025
Q1 | $557K | Sell |
16,291
-11,957
| -42% | -$409K | ﹤0.01% | 1597 |
|
|
2024
Q4 | $784K | Buy |
28,248
+4,646
| +20% | +$129K | ﹤0.01% | 1562 |
|
|
2024
Q3 | $603K | Buy |
+23,602
| New | +$603K | ﹤0.01% | 1566 |
|
|
2024
Q2 | – | Sell |
-11,849
| Closed | -$366K | – | 2556 |
|
|
2024
Q1 | $366K | Buy |
+11,849
| New | +$366K | ﹤0.01% | 1894 |
|
|
2023
Q1 | – | Sell |
-43,184
| Closed | -$317K | – | 2232 |
|
|
2022
Q4 | $317K | Sell |
43,184
-611
| -1% | -$4.48K | ﹤0.01% | 2061 |
|
|
2022
Q3 | $456K | Buy |
43,795
+6,509
| +17% | +$67.8K | ﹤0.01% | 1810 |
|
|
2022
Q2 | $338K | Buy |
37,286
+9,304
| +33% | +$84.3K | ﹤0.01% | 2168 |
|
|
2022
Q1 | $288K | Buy |
+27,982
| New | +$288K | ﹤0.01% | 2412 |
|
|
2021
Q4 | – | Sell |
-21,899
| Closed | -$1.06M | – | 2748 |
|
|
2021
Q3 | $1.06M | Buy |
21,899
+17,655
| +416% | +$854K | ﹤0.01% | 1463 |
|
|
2021
Q2 | $261K | Sell |
4,244
-1,144
| -21% | -$70.4K | ﹤0.01% | 2181 |
|
|
2021
Q1 | $329K | Sell |
5,388
-3,369
| -38% | -$206K | ﹤0.01% | 1882 |
|
|
2020
Q4 | $619K | Buy |
+8,757
| New | +$619K | ﹤0.01% | 1646 |
|